| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | DYDC2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | LRPPRC | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | GZF1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | PUS7 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | NUP210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RPS18 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | PSMB9 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | C5AR1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | VWCE | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
